Systemic Juvenile idiopathic arthritis Continuing PBS authority application Supporting information form (PB118)

You must lodge this form for a patient who is continuing PBS subsidised tocilizumab treatment.

This includes patients who have turned 18 years since the commencement of PBS subsidised treatment, demonstrating a response to PBS subsidised tocilizumab treatment, recommencing treatment with PBS subsidised tocilizumab treatment after a break of less than 12 months. This form must be completed by a paediatric rheumatologist or a prescriber under the supervision of a paediatric rheumatology treatment centre.


Page last updated: 13 July 2016

This information was printed Sunday 2 October 2016 from It may not include all of the relevant information on this topic. Please consider any relevant site notices at when using this material.